Treatment Patterns in Metastatic Prostate Cancer

CompletedOBSERVATIONAL
Enrollment

565

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

January 19, 2017

Study Completion Date

January 19, 2017

Conditions
Prostatic Neoplasm
Interventions
DRUG

Xofigo (Radium 223 dichloride,BAY88-8223)

Retrospective claims analysis. Descriptive analyses of treatment patterns.

Trial Locations (1)

Unknown

Whippany

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Bayer

INDUSTRY